Telaleaf Health Inc.

and Vayamed a Division of Sanity Group Launch Exclusive

Partnership

Telaleaf Health Inc. (or “Telaleaf”), a pioneer in cannabis-based telemedicine, today announced an
exclusive partnership with Berlin-based medical cannabis specialist Vayamed, subsidiary of Sanity
Group, that will provide increased access to medical cannabis to patients in Germany, as well as
education and training programs to doctors on the prescription and treatment of cannabis
medicines.

Berlin, Germany February 08, 2022 --(PR.com)-- Telaleaf, a telemedicine start-up transforming the
access and delivery of medical cannabis care to patients, and medical cannabis brand Vayamed,
subsidiary of Sanity Group, are pleased to announce a strategic partnership to improve access to medical
cannabis care to patients in Germany. This exclusive partnership is focused on the use of telemedicine to
strengthen the delivery of cannabis-based treatments through premier clinical care, better access, superior
treatment quality, individualized treatment plans and patient-centered pricing. The partnership is also
focused on delivering academic and clinical-level training and education to doctors, pharmacists and
other relevant practitioners.

Telaleaf is a pioneer in cannabis-based telemedicine from Canada established in 2020 that allows patients
to book virtual medical visits with cannabis-trained doctors and is now launching its web and mobile app
in the German healthcare system. The app provides a first-of-its kind, end-to-end telemedicine experience
for receiving personalized cannabis care from top specialists, such as world-renown cannabis medicine
pioneer, Franjo Grotenhermen, M.D.

Vayamed and Telaleaf are driven by the vision that telemedicine will continue to move healthcare
delivery from clinic to home, and will become the standard in the delivery of cannabis-based medicine.
Doctor visits to consult about Vayamed products and treatment options are planned as well as further
programs in the field of talent support and expert training at leading medical faculties nationwide.

"The importance of telemedicine in the German healthcare system will continue to grow. It offers many
benefits for doctors, patients and the healthcare system, for example better access and treatment quality,
qualified trainings, and improved health insurance reimbursement levels through special training offers
for doctors. Together with Telaleaf, we want to improve therapies with medical cannabis in Germany
through the utilization of telemedicine," said Thimo V. Schmitt-Lord, Director New Markets &
Innovation at Vayamed.

“In order to fully realize the vision of cannabis-based medicine as the advanced, alternative medicinal
modality it has proven to be, Telaleaf has entirely reimagined the cannabis healthcare delivery model
such that all necessary medical services, tools and resources come together for patients and doctors under
one unified field. Our joint mission with Vayamed is to drive better health outcomes for patients with
personalized virtual care that is sustained by expert-led medicinal cannabis training and education,” said
Telaleaf CEO, Gavin Treanor.

Page 1 of 3
PR.com Press Release Distribution Terms
Telaleaf collaborates with leading experts such as Prof. Kirsten Müller-Vahl, M.D., and Franjo
Grothenhermen, M.D., by whom medical cannabis training for participating doctors is instructed at the
highest educational level, in cooperation with Dresden International University.

About Vayamed

Medical cannabis specialist Vayamed, a brand of Berlin-based health and life science company Sanity
Group, specializes in the development and distribution of innovative cannabinoid-based medicinal
products for the European market and, as a reliable provider, is committed to making medical cannabis
accessible to doctors, pharmacists and patients.

About Sanity Group

Sanity Group, a Berlin-based health and life-science company, aims to improve people’s quality of life
through the use of cannabinoids and the utilization of the endocannabinoid system. The focus is on
pharmaceuticals and medical products (Sanity Medical) on the one hand and cannabinoid-based consumer
goods (Sanity Care) on the other. The mission is to build the leading cannabinoid company for medical
cannabis and consumer health in Europe. Financially and strategically, Sanity Group is supported by
investors such as Redalpine, HV Capital, Calyx, Casa Verde Capital, Navy Capital, Cherry Ventures,
SOJE Capital, Bitburger Ventures, and various business angels such as music producer Will.i.am,
Hollywood actor Alyssa Milano, professional soccer player Mario Götze and German model Stefanie
Giesinger.

About Telaleaf Health Inc.

Telaleaf is a telemedicine company transforming the delivery of cannabis care by connecting patients to
expert doctors, trained in cannabis-based medicine, who conduct virtual medical visits and provide
personalized treatment plans. Our aim is to improve patient outcomes, by improving the patient
experience with high quality treatment, ease of access, and expert-led training to practitioners, for the
most advanced virtual care in cannabis medicine.

Page 2 of 3
PR.com Press Release Distribution Terms
Contact Information:
Telaleaf
Albert Wardi Jr.
1-647-498-0306
Contact via Email
www.telaleaf.com

Online Version of Press Release:

https://www.pr.com/press-release/854584

Page 3 of 3
PR.com Press Release Distribution Terms